← Back to All Stocks
Adaptimmune Therapeutics plc (ADAP) Analysis
Generated on: 2025-06-22 15:03:37 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
Analysis Values
Current Price
$0.26
Predicted Price
$0.29
Expected Return
10.14%
Confidence Score
0.80
RSI (14)
24.36 (buy)
MACD
-0.01
Volume
648,800
Float Shares
1,046,757,646
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249
ADAP
Adaptimmune Therapeutics plc
10.14%
Price: $0.26
Confidence: 0.80
News
RSI Buy
Last updated: 2025-06-22 15:03:37
Technical Analysis
RSI:
24.36 (buy)
MACD: -0.01
Risk Analysis
Volatility
94.05%
Max Drawdown
-85.83%
Beta
1.0
Risk Score
92.0
Social Sentiment
0
Social Sentiment Score (0-100)
Recent News
Adaptimmune Therapeutics PLC (ADAP) Q1 2025 Earnings Call Highlights: Strong Tecelra Launch ...
GuruFocus.com - 2025-05-14 07:05
Adaptimmune Therapeutics PLC (ADAP) reports promising Tecelra sales and operational success, but faces financial sustainability challenges.
Reddit Discussions
No recent Reddit discussions found.
Recent SEC Filings
No recent SEC filings found.
